Contract research
It is a long path from the development of an active pharmaceutical ingredient in the lab to an effective drug – a process that takes several years. Campus companies are often involved in this process on behalf of the pharmaceutical and biotech industry or academic groups.
The company Experimental Pharmacology & Oncology Berlin-Buch (EPO) is a leader in preclinical cancer research in Germany. Worldwide, EPO offers customized and comprehensive service for the preclinical development of novel cancer drugs and is specialized in the development of individualized tumor models.
News innovation
Eckert & Ziegler: Record year 2024 with new all-time highs
Eckert & Ziegler SE (ISIN DE0005659700, TecDAX) achieved a new record in the 2024 financial year with sales of € 295.8 million based on the preliminary annual financial statements*. Compared to the pr...
more ...Eckert & Ziegler and AtomVie Global Radiopharma Sign a Global Agreement for Lutetium-177 Supply
Eckert & Ziegler SE (ISIN DE0005659700, TecDAX) and AtomVie Global Radiopharma Inc. (AtomVie) today announced a global supply agreement. Eckert & Ziegler will provide its high-quality non-carrier adde...
more ...“Jugend forscht” at Campus Berlin-Buch
From better 3D printers for biological structures to soil remediation with microorganisms – in the 60th round of “Jugend forscht,” regional students presented their exciting research projects on the B...
more ...Events Campus
29.04.2025, 16:00
Krebsprävention durch Ernährung und körperliche Aktivität: Wie kommen wir zu wissenschaftlich fundierten Erkenntnissen?
Online-Kurs für Lehrkräfte mit Katharina Nimptsch
more ...23.05.2025, 09:00
WEITERBILDUNGSTAG LABOR 4.0 FÜR TECHNISCHE ANGESTELLTE UND LABORANT*INNEN
28.06.2025, 16:00
Lange Nacht der Wissenschaften 2025
Mitmach-Experimente, Shows, Laborführungen
more ...
